Literature DB >> 26925609

Ultrasound Elastography Is Useful for Evaluation of Liver Fibrosis in Children-A Systematic Review.

Sofie Bech Andersen1, Caroline Ewertsen, Jonathan Frederik Carlsen, Birthe Merete Henriksen, Michael Bachmann Nielsen.   

Abstract

OBJECTIVES: Adult studies have proven ultrasound elastography as a validated measure of liver fibrosis. The present study aimed to review the available literature on ultrasound elastography in children to evaluate the ability of the method to distinguish healthy from fibrotic liver tissue and investigate whether cutoff values for liver fibrosis in children have been established.
METHODS: A literature search was performed in MEDLINE, EMBASE, the Cochrane Library, and Web of Science to identify studies on ultrasound elastography of the liver in children. Only original research articles in English concerning ultrasound elastography in children with and without liver disease, younger than 18 years, were included. All reference lists of the included articles were hand-searched for further references.
RESULTS: Twenty-seven articles were included. Elastography in children without liver disease was investigated in 14 studies and were comparable to those existing for adults. Twelve studies compared elastography with liver biopsy in children with liver disease and found that cirrhosis was correctly diagnosed, whereas it was more difficult to assess severe fibrosis correctly. For the distinction between no, mild, and moderate fibrosis in children with liver disease the method was less accurate. Ultrasound elastography was able to differentiate between children with and without liver fibrosis. In children without liver disease ultrasound, elastography showed consistent liver stiffness values comparable to those found in adults. No fibrosis-specific cutoffs were proposed.
CONCLUSIONS: Ultrasound elastography was able to diagnose cirrhosis, distinguish healthy from fibrotic liver tissue, and showed consistent liver stiffness values in children without liver disease.

Entities:  

Mesh:

Year:  2016        PMID: 26925609     DOI: 10.1097/MPG.0000000000001171

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  6 in total

1.  Hepatic Stiffness Using Shear Wave Elastography and the Related Factors for a Fontan Circulation.

Authors:  Seong-Ook Kim; Sang-Yun Lee; So-Ick Jang; Soo-Jin Park; Hye-Won Kwon; Seong-Ho Kim; Chang-Ha Lee; Eun-Seok Choi; Seong-Kyu Cho; Sun-Hwa Hong; Yang-Min Kim
Journal:  Pediatr Cardiol       Date:  2017-09-21       Impact factor: 1.655

2.  Magnetic resonance elastography in a rabbit model of liver fibrosis: a 3-T longitudinal validation for clinical translation.

Authors:  Liqiu Zou; Jinzhao Jiang; Wenxin Zhong; Chunrong Wang; Wei Xing; Zhuoli Zhang
Journal:  Am J Transl Res       Date:  2016-11-15       Impact factor: 4.060

3.  Normal Liver Stiffness Values in Children: A Comparison of Three Different Elastography Methods.

Authors:  Anders B Mjelle; Anesa Mulabecirovic; Roald F Havre; Karen Rosendahl; Petur B Juliusson; Edda Olafsdottir; Odd H Gilja; Mette Vesterhus
Journal:  J Pediatr Gastroenterol Nutr       Date:  2019-05       Impact factor: 2.839

4.  Noninvasive Evaluation of Liver Fibrosis and Portal Hypertension After Successful Portoenterostomy for Biliary Atresia.

Authors:  Maria Hukkinen; Jouko Lohi; Päivi Heikkilä; Reetta Kivisaari; Timo Jahnukainen; Hannu Jalanko; Mikko P Pakarinen
Journal:  Hepatol Commun       Date:  2019-01-09

5.  Evaluation of Rabbits Liver Fibrosis Using Gd-DTPA-BMA of Dynamic Contrast-Enhanced Magnetic Resonance Imaging.

Authors:  Qian Cui; FengTai He; Jiawei Hu; Shuo Li; Dongmei Guo; Xu Bie; Wei Liu; Yiping Zhao
Journal:  Evid Based Complement Alternat Med       Date:  2021-09-17       Impact factor: 2.629

Review 6.  Hepatitis C virus infection in children in the era of direct-acting antiviral.

Authors:  Malgorzata Pawlowska; Malgorzata Sobolewska-Pilarczyk; Krzysztof Domagalski
Journal:  World J Gastroenterol       Date:  2018-06-28       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.